The Efficacy of Aldose Reductase Inhibitors in the Management of Diabetic Complications

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Drugs & Aging

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002512-199506010-00002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function.

  2009cited by this paper
• Management of non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

  1994cited by this paper
• Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.

  1993cited by this paper
• Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.

  1993cited by this paper
• The diabetes control and complications trial. Implications for policy and practice.

  1993cited by this paper
• Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Diabetic Neuropathy 3 Years After Successful Pancreas and Kidney Transplantation

  1993cited by this paper
• Prevention of diabetic nephropathy. Microalbuminuria and perspectives for intervention in insulin-dependent diabetes.

  1993cited by this paper
• Long-term complications of diabetes mellitus.

  1993cited by this paper
• The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy

  1993cited by this paper
• Cardiovascular reflexes in the neurological evaluation of impotence.

  1993cited by this paper
• Reversal of microangiopathy in long-term diabetic patients after successful simultaneous pancreas-kidney transplants.

  1993cited by this paper
• Epalrestat

  1993cited by this paper
• Aldose Reductase Inhibitors: An Update

  1993cited by this paper
• Aldose reductase inhibitors: recent developments.

  1993cited by this paper
• Causes of Neuropathic Pain

  1993cited by this paper
• Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM Subjects With Nephropathy

  1993cited by this paper
• Long‐term prognosis for diabetic patients with foot ulcers

  1993cited by this paper
• Tight glucose control and diabetic complications.

  1993cited by this paper
• Effects of Ponalrestat, an Aldose Reductase Inhibitor, on Neutrophil Killing of Escherichia Coli and Autonomic Function in Patients With Diabetes Mellitus

  1993cited by this paper
• Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled Trial

  1993cited by this paper
• Effects of Aldose Reductase Inhibitors on the Progression of Nerve Damage

  1993cited by this paper
• Aldose Reductase Inhibitors and the Complications of Diabetes Mellitus

  1993cited by this paper
• Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.

  1993cited by this paper
• Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.

  1993cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy

  1993cited by this paper
• Improvement in autonomic function following pancreas-kidney versus kidney-alone transplantation.

  1993cited by this paper
• Prevalence of diabetic neuropathy with somatic symptoms

  1993cited by this paper
• Hypertension with combined pancreas-kidney transplantation in patients with diabetic nephropathy.

  1993cited by this paper
• Recent Clinical Experience With Aldose Reductase Inhibitors

  1993cited by this paper
• The effect of aldose reductase inhibitor on the corneal epithelium.

  1993cited by this paper
• Pancreatic graft protects a simultaneously transplanted kidney from developing diabetic nephropathy: a 1- to 6-year follow-up study.

  1993cited by this paper
• Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial.

  1992cited by this paper
• Effect of an Aldose Reductase Inhibiting Agent on Limited Joint Mobility in IDDM

  1992cited by this paper
• A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.

  1992cited by this paper
• Aldose reductase inhibitors and diabetic complications.

  1992cited by this paper
• Long-term effects of tolrestat on symptomatic diabetic sensory polyneuropathy.

  1992cited by this paper
• Pathogenesis of Diabetic Microangiopathy: The Roles of Endothelial Cell and Basement Membrane Abnormalities

  1992cited by this paper
• Glucose toxicity in the vascular complications of diabetes: the cellular perspective.

  1992cited by this paper
• Pancreas Transplantation for Patients With Diabetes Mellitus

  1992cited by this paper
• In defence of insulin: a critique of syndrome X.

  1992cited by this paper
• Diabetic Neuropathy: Models, Mechanisms and Mayhem

  1992cited by this paper
• The prevalence and incidence of lower extremity amputation in a diabetic population.

  1992cited by this paper
• Aldose reductase inhibitors--hope or hype.

  1992cited by this paper
• The pharmacology of diabetic neuropathy.

  1992cited by this paper
• Improvement of Nerve Conduction in Diabetic Neuropathy: A Follow-up Study 4 Yr After Combined Pancreatic and Renal Transplantation

  1992cited by this paper
• Discrimination Between Painful and Painless Diabetic Neuropathy Based on Testing of Large Somatic Nerve and Sympathetic Nerve Function

  1992cited by this paper
• Trends in Diabetes and Diabetic Complications, 1980–1987

  1992cited by this paper
• A 12‐Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy

  1992cited by this paper
• Glycemic Control and Diabetic Complications

  1992cited by this paper
• Metabolic control and progression of complications in insulin‐dependent diabetic patients after kidney transplantation

  1992cited by this paper
• Endoneurial Microvessels in Human Diabetic Neuropathy: Endothelial Cell Dysjunction and Lack of Treatment Effect by Aldose Reductase Inhibitor

  1991cited by this paper
• Reduction of Glomerular Hyperfiltration in Normoalbuminuric IDDM Patients by 6 mo of Aldose Reductase Inhibition

  1991cited by this paper
• Clinical and Neurophysiological Studies of Aldose Reductase Inhibitor Ponalrestat in Chronic Symptomatic Diabetic Peripheral Neuropathy

  1991cited by this paper
• The Prevalence and Nature of Podiatric Problems in Elderly Diabetic Patients

  1991cited by this paper
• One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.

  1991cited by this paper
• The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus.

  1991cited by this paper
• Improvement in peripheral nerve function after one year of Sorbinil.

  1991cited by this paper
• Impact of Late Complications in Type 2 Diabetes in a Dutch Population

  1991cited by this paper
• Autonomic and sensory nerve function in diabetic foot ulceration

  1991cited by this paper
• Effect of Aldose Reductase Inhibition on Resistance to Ischemic Conduction Block in Diabetic Subjects

  1991cited by this paper
• Prolonged Aldose Reductase Inhibition in Chronic Peripheral Diabetic Neuropathy: Effects on Microangiopathy

  1990cited by this paper
• Effects of pancreatic transplantation on diabetic neuropathy.

  1990cited by this paper
• Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme.

  1990cited by this paper
• Signs of nerve regeneration and repair following pancreas transplantation in an insulin‐dependent diabetic with neuropathy

  1990cited by this paper
• Diabetic nephropathy. An update.

  1990cited by this paper
• Current progress in clinical trials of aldose reductase inhibitors in Japan.

  1990cited by this paper
• Diabetic retinopathy. A synthesis of perspectives.

  1990cited by this paper
• Influence of Pancreas Transplantation on Cardiorespiratory Reflexes, Nerve Conduction, and Mortality in Diabetes Mellitus

  1990cited by this paper
• Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?

  1990cited by this paper
• The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus.

  1990cited by this paper
• Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS)

  1990cited by this paper
• Association of Painful and Painless Diabetic Polyneuropathy With Different Patterns of Nerve Fiber Degeneration and Regeneration

  1990cited by this paper
• Evidence for a Specific Heart Disease of Diabetes in Humans

  1990cited by this paper
• Pathogenesis of Diabetic Neuropathy: the Role of the n‐6 Essential Fatty Acids and their Eicosanoid Derivatives

  1990cited by this paper
• The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes.

  1989cited by this paper
• Hypoxic neuropathy Does hypoxia play a role in diabetic neuropathy?

  1989cited by this paper
• Meaningful Degrees of Prevention or Improvement of Nerve Conduction in Controlled Clinical Trials of Diabetic Neuropathy

  1989cited by this paper
• Evidence for reversibility of diabetic microangiopathy following pancreas transplantation.

  1989cited by this paper
• Prevalence of Neuropathy in Newly Diagnosed NIDDM and Nondiabetic Control Subjects

  1989cited by this paper
• Chronic and Remitting Painful Diabetic Polyneuropathy: Correlations With Clinical Features and Subsequent Changes in Neurophysiology

  1988cited by this paper
• Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.

  1988cited by this paper
• Aldose Reductase Inhibition in Diabetic Neuropathy: Clinical and Neurophysiological Studies of one Year's Treatment with Sorbinil

  1988cited by this paper
• Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus.

  1988cited by this paper
• Free radicals and diabetes.

  1988cited by this paper
• Long-Term Follow-Up of Polyneuropathy in Diabetic Kidney Transplant Recipients

  1988cited by this paper
• Understanding diabetic neuropathy.

  1988cited by this paper
• The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure.

  1988cited by this paper
• Are Disturbances of Sorbitol, Phosphoinositide, and Na+-K+-ATPase Regulation Involved in Pathogenesis of Diabetic Neuropathy?

  1988cited by this paper
• Diabetic complications of the central nervous system.

  1988cited by this paper
• Diabetic retinopathy. A clinical overview.

  1988cited by this paper
• Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes

  1988cited by this paper
• Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients.

  1988cited by this paper
• Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy.

  1988cited by this paper
• Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy

  1988cited by this paper
• Aldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper

• Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches

  2022cites this paper
• Effects of short term high fat diet on obesity and perivascular adipose structure and function in mice : role of aldose reductase, and aldehyde metabolizing enzyme.

  2013cites this paper
• Mecanismos generadores y consideraciones terapéuticas futuras de la polineuropatía diabética dolorosa

  2008cites this paper
• The Association of Aldose Reductase Gene Polymorphisms with Neuropathy in Patients with Type 2 Diabetes

  2007cites this paper
• Respuesta al tratamiento de la neuropatía diabética dolorosa

  2006cites this paper
• Maintaining the Redox-Balance Intact: Gosha-Jinki-Gan but Not Insulin Activates Retinal Soluble Guanylate Cyclase in Diabetic Rats

  2006cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Hyperglycemia Triggers Abnormal Signaling and Proliferative Responses in Schwann Cells

  2002cites this paper
• Effects of sulbutiamine on diabetic polyneuropathy: an open randomised controlled study in type 2 diabetics.

  2002cites this paper
• Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy.

  1998cites this paper
• Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene

  1998cites this paper
• Aldose reductase: a window to the treatment of diabetic complications?

  1998cites this paper
• Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

  1997cites this paper
• Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated With the Development of Diabetic Nephropathy in Type I Diabetes

  1997cites this paper
• Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy

  1997cites this paper
• Diabetes and the nervous system.

  1996cites this paper
• Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

  1996cites this paper
• early diabetic retinopathy . Hyperoxia improves contrast sensitivity in

  year unknowncites this paper